Full Name Florence Comite Title Endocrinologist Nationality American Website Official website | Occupation Medical Doctor Name Florence Comite Employer ComiteMD | |
 | ||
Known for Associate Clinical Professor Yale University School of Medicine | ||
Dr florence comite leader on precision medicine today show with prevention magazine
Dr. Florence Comite is an endocrinologist who has helped develop new therapies for osteoporosis, endometriosis, fibroid disease, and infertility. She is known for patent approval for developing a new method of determining fertility in women In 1990, Dr. Comite was awarded a second patent for the use of clomifene to increase bone mass in premenopausal women.
Contents
- Dr florence comite leader on precision medicine today show with prevention magazine
- Clinical genetics and epigenetics precision medicine for age management by florence comite md
- Field of study
- Practice
- Education and early career
- Awards and recognition
- Publications
- References
Clinical genetics and epigenetics precision medicine for age management by florence comite md
Field of study
Dr. Comite is known for having an integrated approach to health care delivery using precision medicine. She has done extensive research on hormonal changes and aging, and in particular, issues of Hypogonadism (Low T) in men and how it impacts the onset of certain associated diseases such as type 2 diabetes, heart disease.
Her research involves studying delivery systems and how they impact health outcomes; it has been her focus as a Senior Clinical and Research Adviser to the Offices of Alternative Medicine (OAM) at NIH.
Practice
In addition to her research, Comite's practice in New York City is based on a philosophical concept of the innate uniqueness of each human. Her method begins with the collecting of data on a patient to address the individual’s status via what Comite refers to as a precision health analysis. Dr. Comite’s focus is on personalized treatment paths based on customized tracts incorporating unique aspects for each patient based on a myriad of variables such as lifestyle, metabolism, hormonal and genetic factors, in conjunction with evidence-based medicine to help patients best manage their aging process. Comite also works on helping males deal with what she refers to as Male Menopause.
Education and early career
Comite graduated Summa Cum Laude from Brooklyn College of the City University of New York Yale University School of Medicine; she was an Associate Clinical Professor on the Yale faculty for 25 years; as a leader in women's health for over 15 years, she first founded Women's Health at Yale in 1988. Dr. Comite completed a fellowship in Reproductive Endocrinology, incorporating training in Medicine, Pediatrics, Gynecology and Andrology, at the National Institute of Child Health and Human Development at NIH. In the early 1980, she was researching the use of Gonadotropin-releasing hormones to treat precocious puberty.
Comite had researched in the area of complementary and alternative medicine (CAM), and was recognized by the National Academy of Science's Institute of Medicine's (IOM), where she was elected to the IOM’s Complementary and Alternative Medicine Committee in 2003.
Dr. Comite has served on advisory councils and committees with the NIH, the Egyptian Ministry of Health, and on the Balance Documentary Medical Advisory Board, the Age Management Medicine Group, Independent Doctors of New York, and the American Fertility Society as well as Alpha Omega Alpha.
Awards and recognition
Dr. Comite won the Salk scholarship award for original research at Brooklyn College, the Louis Welt Award at Yale Medical School, the Alan P. Mintz, MD Award for Clinical Excellence in Age Management Medicine, and has been the recipient of additional awards for original research throughout her career.
Publications
Comite has been published in the New England Journal of Medicine, and the Journal of Clinical Endocrinology and Metabolism.
In June 2013 Comite published a work focused on male menopause, entitled: “Hormonal Expression of Androgen Deficiency in Aging Men (ADAM),” the findings were presented at the Endocrine Society in San Francisco.